PMC8792388_01
(A) HE staining showing the fibromatosis. (B) Fluorescence in situ hybridization(FISH) detection:3p22/3 = 0.72,CTNNB1 gene deletion. Probe type: CSP3/GSP CTNNB1 (3p22).
fonc-11-830672-g001.jpg
PMC8792388_01_fonc-11-830672-g001.jpg
f1
Probe type: CSP3/GSP CTNNB1 (3p22) ( Figure 1 ). Immunohistochemical staining was performed and showed CK(-), CD34(vascular+), SOX-10(-), Bcl-2 (-),beta- catenin(+), SMA(-), Desmin(-), Ki-67 (about 1%), CD117 (-), Dog-1 (-), ER-, PR- ( Supplementary Figure 1 ).
The soft tissue mass in the left lower abdomen was scanned with enhanced computed tomography at different time points.
fonc-11-830672-g002.jpg
PMC8792388_01_fonc-11-830672-g002.jpg
f2
The abdominal mass was significantly reduced after treatment ( Figure 2 ).
The change of the diameter of the soft tissue mass in the left lower abdomen at different time points.
fonc-11-830672-g003.jpg
PMC8792388_01_fonc-11-830672-g003.jpg
f3
The treatment efficacy reached PR (partial response) ( Figure 3 ), and the NRS score (2020-10-15) was 0 points ( Figure 4 ).
The changes of the dosage of OxyContin and the changes of NRS scores after treatment at different time points.
fonc-11-830672-g004.jpg
PMC8792388_01_fonc-11-830672-g004.jpg
f4
The treatment efficacy reached PR (partial response) ( Figure 3 ), and the NRS score (2020-10-15) was 0 points ( Figure 4 ).